Flixzon Pharmaceuticals Private Limited
About Flixzon Pharmaceuticals Private Limited
Data last updated:
Flixzon Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 23 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24297MP2021PTC057602. Its GSTIN is 23AAECF7372B1ZY (Madhya Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyansh Jain and Navnit Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 274A Usha Nagar Extension, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.7 Lakh, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹92,449 (net margin 1.9%) and EBITDA of ₹3.78 Lakh (EBITDA margin 7.9%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address274A Usha Nagar Extension, Indore, Madhya Pradesh, India – 452009
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Flixzon Pharmaceuticals Private Limited
The main business activity of Flixzon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Flixzon Pharmaceuticals Private Limited FY 2025 filings available
Flixzon Pharmaceuticals Private Limited reported revenue of ₹47.7 Lakh (up 58% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Flixzon Pharmaceuticals Private Limited
Revenue rose 58% in the latest year. EBITDA rose 132% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Flixzon Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹3.78 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹92,449 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Flixzon Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 7.9% | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Flixzon Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Voctor Pharmaceuticals Private Limited | ₹47.91 Lakh (FY 2024) | •••• | •••• | 103.0% | •••• | Mumbai, Maharashtra, India |
| Sjaldine Pharmaceuticals Private Limited | ₹47.85 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Telibagh, Uttar Pradesh, India |
| Veda Cure Private Limited | ₹47.82 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Indore, Madhya Pradesh, India |
| Aknit Pharmaceuticals Private Limited | ₹47.81 Lakh (FY 2023) | •••• | •••• | 33.0% | •••• | Rewa, Madhya Pradesh, India |
| Genako Pharma Private Limited | ₹47.78 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kharadi Road, Pune, Maharashtra, India |
| Flixzon Pharmaceuticals Private Limited this company | ₹47.7 Lakh (FY 2024) | •••• | •••• | 58.0% | •••• | Indore, Madhya Pradesh, India |
| Seijun Pharmaceuticals Private Limited | ₹47.7 Lakh (FY 2024) | •••• | •••• | 46.0% | •••• | Hyderabad, Telangana, India |
| Med Mines Pharmaceuticals Private Limited | ₹47.6 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Kanpur, Uttar Pradesh, India |
| Organext Pharmaceuticals Private Limited | ₹47.58 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Jaipur, Rajasthan, India |
| Riken Pharmaceuticals Private Limited | ₹47.58 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Delhi, India |
| Bharatam Jayate Pharmacy Private Limited | ₹47.57 Lakh (FY 2024) | •••• | •••• | 23267.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Flixzon Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyansh Jain | Director | 23 Sep 2021 | 5 Years 0 Months | Current |
| Navnit Jain | Director | 23 Sep 2021 | 5 Years 0 Months | Current |
Ownership and Shareholding of Flixzon Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Flixzon Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2022 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Navnit Jain was appointed as Director on 23 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Flixzon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Flixzon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Flixzon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECF7372B1ZY | Madhya Pradesh | Active | 04 Mar 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Flixzon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flixzon Pharmaceuticals Private Limited
Flixzon Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 23 September 2021 (5+ years old) and is registered under CIN U24297MP2021PTC057602.
Flixzon Pharmaceuticals reported revenue of ₹47.7 Lakh for FY 2024 (up 58% YoY).
Flixzon Pharmaceuticals has 2 current directors:
- Priyansh Jain - Director
- Navnit Jain - Director
Flixzon Pharmaceuticals reported a net profit of ₹92,449 (net margin 1.9%) and EBITDA of ₹3.78 Lakh (EBITDA margin 7.9%) for FY 2024, as per its filed financial statements.
The GSTIN of Flixzon Pharmaceuticals is 23AAECF7372B1ZY, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Flixzon Pharmaceuticals is U24297MP2021PTC057602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Flixzon Pharmaceuticals was incorporated on 23 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Flixzon Pharmaceuticals by revenue are Voctor Pharmaceuticals Private Limited, Sjaldine Pharmaceuticals Private Limited, Veda Cure Private Limited, Aknit Pharmaceuticals Private Limited, Genako Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Navnit Jain was appointed as Director on 23 Sep 2021. Priyansh Jain was appointed as Director on 23 Sep 2021.
The registered office of Flixzon Pharmaceuticals is at 274A Usha Nagar Extension, Indore, Madhya Pradesh, India – 452009.
Flixzon Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.